vs

Side-by-side financial comparison of ASP Isotopes Inc. (ASPI) and Orion S.A. (OEC). Click either name above to swap in a different company.

Orion S.A. is the larger business by last-quarter revenue ($411.7M vs $16.7M, roughly 24.7× ASP Isotopes Inc.). On growth, ASP Isotopes Inc. posted the faster year-over-year revenue change (1295.7% vs -5.2%). Orion S.A. produced more free cash flow last quarter ($44.2M vs $-47.4M). Over the past eight quarters, ASP Isotopes Inc.'s revenue compounded faster (345.2% CAGR vs -9.5%).

ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

ASPI vs OEC — Head-to-Head

Bigger by revenue
OEC
OEC
24.7× larger
OEC
$411.7M
$16.7M
ASPI
Growing faster (revenue YoY)
ASPI
ASPI
+1300.9% gap
ASPI
1295.7%
-5.2%
OEC
More free cash flow
OEC
OEC
$91.6M more FCF
OEC
$44.2M
$-47.4M
ASPI
Faster 2-yr revenue CAGR
ASPI
ASPI
Annualised
ASPI
345.2%
-9.5%
OEC

Income Statement — Q4 2025 vs Q4 2025

Metric
ASPI
ASPI
OEC
OEC
Revenue
$16.7M
$411.7M
Net Profit
Gross Margin
12.5%
18.9%
Operating Margin
4.3%
Net Margin
Revenue YoY
1295.7%
-5.2%
Net Profit YoY
-586.8%
EPS (diluted)
$-0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPI
ASPI
OEC
OEC
Q4 25
$16.7M
$411.7M
Q3 25
$4.9M
$450.9M
Q2 25
$1.2M
$466.4M
Q1 25
$1.1M
$477.7M
Q4 24
$1.2M
$434.2M
Q3 24
$1.1M
$463.4M
Q2 24
$1.0M
$477.0M
Q1 24
$840.4K
$502.9M
Net Profit
ASPI
ASPI
OEC
OEC
Q4 25
Q3 25
$-12.9M
$-67.1M
Q2 25
$-75.2M
$9.0M
Q1 25
$-8.5M
$9.1M
Q4 24
Q3 24
$-7.4M
$-20.2M
Q2 24
$-8.9M
$20.5M
Q1 24
$-7.0M
$26.7M
Gross Margin
ASPI
ASPI
OEC
OEC
Q4 25
12.5%
18.9%
Q3 25
8.7%
19.0%
Q2 25
47.7%
21.1%
Q1 25
29.7%
20.5%
Q4 24
50.7%
20.6%
Q3 24
27.0%
23.2%
Q2 24
41.2%
23.0%
Q1 24
33.2%
24.3%
Operating Margin
ASPI
ASPI
OEC
OEC
Q4 25
4.3%
Q3 25
-306.1%
-11.9%
Q2 25
-998.8%
6.9%
Q1 25
-721.9%
6.5%
Q4 24
5.4%
Q3 24
-499.6%
-3.3%
Q2 24
-729.5%
8.7%
Q1 24
-691.9%
10.5%
Net Margin
ASPI
ASPI
OEC
OEC
Q4 25
Q3 25
-263.7%
-14.9%
Q2 25
-6271.7%
1.9%
Q1 25
-768.1%
1.9%
Q4 24
Q3 24
-676.2%
-4.4%
Q2 24
-868.8%
4.3%
Q1 24
-828.8%
5.3%
EPS (diluted)
ASPI
ASPI
OEC
OEC
Q4 25
$-0.36
Q3 25
$-0.15
$-1.20
Q2 25
$-1.03
$0.16
Q1 25
$-0.12
$0.16
Q4 24
$0.31
Q3 24
$-0.12
$-0.35
Q2 24
$-0.24
$0.35
Q1 24
$-0.16
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPI
ASPI
OEC
OEC
Cash + ST InvestmentsLiquidity on hand
$333.3M
$60.7M
Total DebtLower is stronger
$14.4M
Stockholders' EquityBook value
$204.2M
$384.6M
Total Assets
$498.0M
$1.9B
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPI
ASPI
OEC
OEC
Q4 25
$333.3M
$60.7M
Q3 25
$113.9M
$51.3M
Q2 25
$67.7M
$42.6M
Q1 25
$56.0M
$37.5M
Q4 24
$61.9M
$44.2M
Q3 24
$51.6M
$53.2M
Q2 24
$34.2M
Q1 24
$43.9M
Total Debt
ASPI
ASPI
OEC
OEC
Q4 25
$14.4M
Q3 25
$13.9M
Q2 25
Q1 25
Q4 24
$2.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ASPI
ASPI
OEC
OEC
Q4 25
$204.2M
$384.6M
Q3 25
$74.1M
$401.8M
Q2 25
$25.2M
$466.5M
Q1 25
$42.5M
$466.1M
Q4 24
$47.9M
$474.9M
Q3 24
$38.7M
$476.3M
Q2 24
$11.0M
$503.9M
Q1 24
$10.5M
$492.2M
Total Assets
ASPI
ASPI
OEC
OEC
Q4 25
$498.0M
$1.9B
Q3 25
$225.9M
$2.0B
Q2 25
$135.9M
$2.0B
Q1 25
$90.9M
$2.0B
Q4 24
$94.3M
$1.9B
Q3 24
$84.1M
$2.0B
Q2 24
$54.8M
$1.9B
Q1 24
$45.4M
$1.9B
Debt / Equity
ASPI
ASPI
OEC
OEC
Q4 25
0.07×
Q3 25
0.19×
Q2 25
Q1 25
Q4 24
0.05×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPI
ASPI
OEC
OEC
Operating Cash FlowLast quarter
$-37.8M
$92.9M
Free Cash FlowOCF − Capex
$-47.4M
$44.2M
FCF MarginFCF / Revenue
-284.7%
10.7%
Capex IntensityCapex / Revenue
57.9%
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-74.6M
$54.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPI
ASPI
OEC
OEC
Q4 25
$-37.8M
$92.9M
Q3 25
$-8.9M
$68.8M
Q2 25
$-7.9M
$53.7M
Q1 25
$-3.2M
$400.0K
Q4 24
$-16.7M
$94.5M
Q3 24
$-4.8M
$-30.9M
Q2 24
$-5.1M
$29.3M
Q1 24
$-3.0M
$32.4M
Free Cash Flow
ASPI
ASPI
OEC
OEC
Q4 25
$-47.4M
$44.2M
Q3 25
$-12.0M
$27.9M
Q2 25
$-9.7M
$11.5M
Q1 25
$-5.5M
$-28.8M
Q4 24
$-26.4M
$23.5M
Q3 24
$-9.3M
$-78.8M
Q2 24
$-7.7M
$-25.4M
Q1 24
$-4.2M
$-700.0K
FCF Margin
ASPI
ASPI
OEC
OEC
Q4 25
-284.7%
10.7%
Q3 25
-245.5%
6.2%
Q2 25
-809.4%
2.5%
Q1 25
-497.4%
-6.0%
Q4 24
-2209.3%
5.4%
Q3 24
-857.3%
-17.0%
Q2 24
-757.8%
-5.3%
Q1 24
-501.7%
-0.1%
Capex Intensity
ASPI
ASPI
OEC
OEC
Q4 25
57.9%
11.8%
Q3 25
64.4%
9.1%
Q2 25
150.1%
9.0%
Q1 25
209.6%
6.1%
Q4 24
810.5%
16.4%
Q3 24
412.3%
10.3%
Q2 24
256.5%
11.5%
Q1 24
148.3%
6.6%
Cash Conversion
ASPI
ASPI
OEC
OEC
Q4 25
Q3 25
Q2 25
5.97×
Q1 25
0.04×
Q4 24
Q3 24
Q2 24
1.43×
Q1 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPI
ASPI

Segment breakdown not available.

OEC
OEC

Rubber$272.0M66%
Specialties$139.7M34%

Related Comparisons